MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent(211 views) Anemone A, Consolino L, Longo DL
Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, Università degli Studi di Torino, Torino, Italy
Istituto di Biostrutture e Bioimmagini (CNR) c/o Centro di Biotecnologie Molecolari, Università degli Studi di Torino, Via Nizza 52, Torino, 10126, Italy
References: Hylton, N., Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker (2006) J Clin Oncol, 24, pp. 3293-3298. , COI: 1:CAS:528:DC%2BD28Xot1yhsrw%3D, PID: 1682965
Dawson, P., Functional imaging in CT (2006) Eur J Radiol, 60, pp. 331-340. , PID: 16979314
Miles, K.A., Functional computed tomography in oncology (2002) Eur J Cancer, 38, pp. 2079-2084. , COI: 1:STN:280:DC%2BD38njtValsg%3D%3D, PID: 12387833
Winfield, J.M., Payne, G.S., deSouza, N.M., Functional MRI and CT biomarkers in oncology (2015) Eur J Nucl Med Mol Imaging, 42, pp. 562-578. , COI: 1:CAS:528:DC%2BC2MXosFCrtQ%3D%3D, PID: 25578953
Morana, G., Cugini, C., Scatto, G., Zanato, R., Fusaro, M., Dorigo, A., Use of contrast agents in oncological imaging: magnetic resonance imaging (2013) Cancer Imaging, 13, pp. 350-359. , PID: 24060901
Pierre, V.C., Allen, M.J., Caravan, P., Contrast agents for MRI: 30+ years and where are we going? (2014) J Biol Inorg Chem, 19, pp. 127-131. , COI: 1:CAS:528:DC%2BC2cXmtVajsw%3D%3D, PID: 24414380
Grobner, T., Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? (2006) Nephrol Dial Transplant, 21, pp. 1104-1108. , COI: 1:CAS:528:DC%2BD28XivVOntb8%3D, PID: 16431890
Yang, L., Krefting, I., Gorovets, A., Nephrogenic systemic fibrosis and class labeling of gadolinium-based contrast agents by the Food and Drug Administration (2012) Radiology, 265, pp. 248-253. , PID: 22923714
Thomsen, H.S., Morcos, S.K., Almen, T., Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines (2013) Eur Radiol, 23, pp. 307-318. , PID: 22865271
Idee, J.M., Fretellier, N., Robic, C., Corot, C., The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update (2014) Crit Rev Toxicol, 44, pp. 895-913. , COI: 1:CAS:528:DC%2BC2cXhvVOgurrN, PID: 25257840
Aime, S., Caravan, P., Biodistribution of gadolinium-based contrast agents, including gadolinium deposition (2009) J Magn Reson Imaging, 30, pp. 1259-1267. , PID: 19938038
Kanda, T., Ishii, K., Kawaguchi, H., Kitajima, K., Takenaka, D., High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material (2014) Radiology, 270, pp. 834-841. , PID: 24475844
Quattrocchi, C.C., Mallio, C.A., Errante, Y., Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy (2015) Investig Radiol, 50, pp. 470-472
Radbruch, A., Weberling, L.D., Kieslich, P.J., Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent (2015) Radiology, 275, pp. 783-791. , PID: 25848905
Halvorsen, R.A., Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR Imaging (2008) Radiology, 249, pp. 9-15. , PID: 18796664
Dawson, P., Blomley, M.J.K., Contrast media as extracellular fluid space markers: Adaptation of the central volume theorem (1996) Br J Radiol, 69, pp. 717-722. , COI: 1:STN:280:DyaK2s7gs12htw%3D%3D, PID: 8949673
van Zijl, P.C., Yadav, N.N., Chemical exchange saturation transfer (CEST): what is in a name and what isn't? (2011) Magn Reson Med, 65, pp. 927-948. , PID: 21337419
Vinogradov, E., Sherry, A.D., Lenkinski, R.E., CEST: from basic principles to applications, challenges and opportunities (2013) J Magn Reson, 229, pp. 155-172. , COI: 1:CAS:528:DC%2BC38XhvFWhs7bK, PID: 23273841
Liu, G., Song, X., Chan, K.W., McMahon, M.T., Nuts and bolts of chemical exchange saturation transfer MRI (2013) NMR Biomed, 26, pp. 810-828. , PID: 23303716
Castelli, D.D., Terreno, E., Longo, D., Aime, S., Nanoparticle-based chemical exchange saturation transfer (CEST) agents (2013) NMR Biomed, 26, pp. 839-849. , COI: 1:CAS:528:DC%2BC3sXpvFers74%3D, PID: 23784956
Terreno, E., Castelli, D.D., Aime, S., Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents (2010) Contrast Media Mol Imaging, 5, pp. 78-98. , COI: 1:CAS:528:DC%2BC3cXltFKisLc%3D, PID: 20419761
Longo, D.L., Dastru, W., Digilio, G., Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys: In vivo studies in mice at 7 T (2011) Magn Reson Med, 65, pp. 202-211. , COI: 1:CAS:528:DC%2BC3MXhvFCntbo%3D, PID: 20949634
Aime, S., Calabi, L., Biondi, L., Iopamidol: Exploring the potential use of a well-established x-ray contrast agent for MRI (2005) Magn Reson Med, 53, pp. 830-834. , COI: 1:CAS:528:DC%2BD2MXjs1Ohtrg%3D, PID: 15799043
Müller-Lutz, A., Khalil, N., Schmitt, B., Pilot study of Iopamidol-based quantitative pH imaging on a clinical 3T MR scanner (2014) MAGMA
Longo, D.L., Michelotti, F., Consolino, L., In Vitro and in vivo assessment of nonionic iodinated radiographic molecules as chemical exchange saturation transfer magnetic resonance imaging tumor perfusion agents (2016) Invest Radiol, 51, pp. 155-162
Chen, S.Z., Yuan, J., Deng, M., Wei, J., Zhou, J., Wang, Y.J., Chemical exchange saturation transfer (CEST) MR technique for in-vivo liver imaging at 3.0 tesla (2016) Eur Radiol, 26, pp. 1792-1800
Li, C., Peng, S., Wang, R., Chemical exchange saturation transfer MR imaging of Parkinson's disease at 3 Tesla (2014) Eur Radiol, 24, pp. 2631-2639. , PID: 25038850
Jiang, S., Yu, H., Wang, X., Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla (2016) Eur Radiol, 26, pp. 64-71. , PID: 25925361
Zaiss, M., Windschuh, J., Goerke, S., Downfield-NOE-suppressed amide-CEST-MRI at 7 Tesla provides a unique contrast in human glioblastoma (2016) Magn Reson Med
Donahue, M.J., Donahue, P.C., Rane, S., Assessment of lymphatic impairment and interstitial protein accumulation in patients with breast cancer treatment-related lymphedema using CEST MRI (2016) Magn Reson Med, 75, pp. 345-355. , COI: 1:CAS:528:DC%2BC2MXitVentb%2FL, PID: 25752499
Cai, K., Singh, A., Poptani, H., CEST signal at 2ppm (CEST@2ppm) from Z-spectral fitting correlates with creatine distribution in brain tumor (2015) NMR Biomed, 28, pp. 1-8. , COI: 1:CAS:528:DC%2BC2cXitVektLbM, PID: 25295758
Longo, D.L., Busato, A., Lanzardo, S., Antico, F., Aime, S., Imaging the pH evolution of an acute kidney injury model by means of iopamidol, a MRI-CEST pH-responsive contrast agent (2013) Magn Reson Med, 70, pp. 859-864. , COI: 1:CAS:528:DC%2BC3sXhtlKrtrrJ, PID: 23059893
Chen, L.Q., Howison, C.M., Jeffery, J.J., Robey, I.F., Kuo, P.H., Pagel, M.D., Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI (2014) Magn Reson Med, 72, pp. 1408-1417
Longo, D.L., Sun, P.Z., Consolino, L., Michelotti, F.C., Uggeri, F., Aime, S., A general MRI-CEST ratiometric approach for pH imaging: demonstration of in vivo pH mapping with lobitridol (2014) J Am Chem Soc, 136, pp. 14333-14336. , COI: 1:CAS:528:DC%2BC2cXhsFyjur7F, PID: 25238643
Chen, L.Q., Randtke, E.A., Jones, K.M., Moon, B.F., Howison, C.M., Pagel, M.D., Evaluations of tumor acidosis within in vivo tumor models using parametric maps generated with AcidoCEST MRI (2015) Mol Imaging Biol, 17, pp. 488-496
Jones, K.M., Randtke, E.A., Howison, C.M., Measuring extracellular pH in a lung fibrosis model with acidoCEST MRI (2015) Mol Imaging Biol, 17, pp. 177-184. , COI: 1:CAS:528:DC%2BC28Xht1Smur%2FO, PID: 25187227
Terreno, E., Stancanello, J., Longo, D., Methods for an improved detection of the MRI-CEST effect (2009) Contrast Media Mol Imaging, 4, pp. 237-247. , COI: 1:CAS:528:DC%2BD1MXht12msb3M, PID: 19839029
Lavini, C., Verhoeff, J.J., Majoie, C.B., Stalpers, L.J., Richel, D.J., Maas, M., Model-based, semiquantitative and time intensity curve shape analysis of dynamic contrast-enhanced MRI: a comparison in patients undergoing antiangiogenic treatment for recurrent glioma (2011) J Magn Reson Imaging, 34, pp. 1303-1312. , PID: 21954019
Holden, G., Statistical power analysis for the behavioral-sciences, 2nd edition - cohen (1993) J Soc Work Health Care, 18, pp. 131-132
Iagaru, A., Gambhir, S.S., Imaging tumor angiogenesis: the road to clinical utility (2013) AJR Am J Roentgenol, 201, pp. W183-W191. , PID: 23883233
Brix, G., Griebel, J., Kiessling, F., Wenz, F., Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements (2010) Eur J Nucl Med Mol Imaging, 37, pp. S30-S51. , PID: 20503049
Kim, J.H., Kim, H.J., Lee, K.H., Kim, K.H., Lee, H.L., Solitary pulmonary nodules: a comparative study evaluated with contrast-enhanced dynamic MR imaging and CT (2004) J Comput Assist Tomogr, 28, pp. 766-775. , PID: 15538149
Kierkels, R.G., Backes, W.H., Janssen, M.H., Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer (2010) Int J Radiat Oncol Biol Phys, 77, pp. 400-408. , PID: 19733445
Xu, X., Yadav, N.N., Knutsson, L., Dynamic glucose-enhanced (DGE) MRI: translation to human scanning and first results in glioma patients (2015) Tomography, 1, pp. 105-114. , PID: 26779568
Xu, X., Chan, K.W., Knutsson, L., Dynamic glucose enhanced (DGE) MRI for combined imaging of blood-brain barrier break down and increased blood volume in brain cancer (2015) Magn Reson Med, 74, pp. 1556-1563. , COI: 1:CAS:528:DC%2BC2MXhvFWls7%2FO, PID: 26404120
Murakami, M., Ernsting, M.J., Undzys, E., Holwell, N., Foltz, W.D., Li, S.D., Docetaxel conjugate nanoparticles that target alpha-smooth muscle actin-expressing stromal cells suppress breast cancer metastasis (2013) Cancer Res, 73, pp. 4862-4871. , COI: 1:CAS:528:DC%2BC3sXht1SksrrL, PID: 23907638
Yankeelov, T.E., DeBusk, L.M., Billheimer, D.D., Repeatability of a reference region model for analysis of murine DCE-MRI data at 7T (2006) J Magn Reson Imaging, 24, pp. 1140-1147. , PID: 17024660
Rutten, A., Prokop, M., Contrast agents in X-ray computed tomography and its applications in oncology (2007) Anticancer Agents Med Chem, 7, pp. 307-316. , COI: 1:CAS:528:DC%2BD2sXksVWhurw%3D, PID: 17504157
Aime, S., Botta, M., Terreno, E., Gd(III)-based contrast agents for MRI (2005) Adv Inorg Chem - Incl Bioinorg Stud, 57, pp. 173-237. , COI: 1:CAS:528:DC%2BD2MXktVSktbg%3D
Laurent, S., Elst, L.V., Muller, R.N., Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents (2006) Contrast Media Mol Imaging, 1, pp. 128-137. , COI: 1:CAS:528:DC%2BD28Xpt1ShsbY%3D, PID: 17193689
MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent
Malvindi MA, Greco A, Conversano F, Figuerola A, Corti M, Bonora M, Lascialfari A, Doumari HA, Moscardini M, Cingolani R, Gigli G, Casciaro S, Pellegrino T, Ragusa A * MR Contrast Agents(292 views) Small Animal Imaging, 2011 Jul 8; 21(13): 2548-2555. Impact Factor:1.784 ViewExport to BibTeXExport to EndNote